HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC

Clinical trial NCT03020342 · UNKNOWN

Trial details

NCT number: NCT03020342
Sponsor: National Taiwan University Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Carcinoma, Hepatocellular

Start date: 2016-05-01
Primary completion: 2019-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.